Point of Care Glucose Testing Market Analysis 2026

Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))

• 1.1 Top Competitors Analysis
  • 1.1.1 Global Point of Care Glucose Testing Market Analysis by Key Players
  • 1.1.2 Segment Market Analysis by Key Players
  • 1.1.3 Top Players Ranking 2024
  • 1.1.4 New Product Launch Analysis
  • 1.1.5 Industry Mergers and Acquisition Analysis
• 1.2 Company Profile (Data Subject to Availability) Sample Format
  • 1.2.1 Abbott (U.S.)
    • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.1.2 Business Overview
    • 1.2.1.3 Financials (Subject to data availability)
    • 1.2.1.4 R&D Investment (Subject to data availability)
    • 1.2.1.5 Product Types Specification
    • 1.2.1.6 Business Strategy
    • 1.2.1.7 Recent Developments
    • 1.2.1.8 Management Change
    • 1.2.1.9 S.W.O.T Analysis
  • 1.2.2 Dexcom (U.S.)
    • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.2.2 Business Overview
    • 1.2.2.3 Financials (Subject to data availability)
    • 1.2.2.4 R&D Investment (Subject to data availability)
    • 1.2.2.5 Product Types Specification
    • 1.2.2.6 Business Strategy
    • 1.2.2.7 Recent Developments
    • 1.2.2.8 Management Change
    • 1.2.2.9 S.W.O.T Analysis
  • 1.2.3 Roche (Switzerland)
    • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.3.2 Business Overview
    • 1.2.3.3 Financials (Subject to data availability)
    • 1.2.3.4 R&D Investment (Subject to data availability)
    • 1.2.3.5 Product Types Specification
    • 1.2.3.6 Business Strategy
    • 1.2.3.7 Recent Developments
    • 1.2.3.8 Management Change
    • 1.2.3.9 S.W.O.T Analysis
  • 1.2.4 Ascensia Diabetes Care (Switzerland)
    • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.4.2 Business Overview
    • 1.2.4.3 Financials (Subject to data availability)
    • 1.2.4.4 R&D Investment (Subject to data availability)
    • 1.2.4.5 Product Types Specification
    • 1.2.4.6 Business Strategy
    • 1.2.4.7 Recent Developments
    • 1.2.4.8 Management Change
    • 1.2.4.9 S.W.O.T Analysis
  • 1.2.5 LifeScan (U.S.)
    • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.5.2 Business Overview
    • 1.2.5.3 Financials (Subject to data availability)
    • 1.2.5.4 R&D Investment (Subject to data availability)
    • 1.2.5.5 Product Types Specification
    • 1.2.5.6 Business Strategy
    • 1.2.5.7 Recent Developments
    • 1.2.5.8 Management Change
    • 1.2.5.9 S.W.O.T Analysis
  • 1.2.6 Medtronic (U.S.)
    • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.6.2 Business Overview
    • 1.2.6.3 Financials (Subject to data availability)
    • 1.2.6.4 R&D Investment (Subject to data availability)
    • 1.2.6.5 Product Types Specification
    • 1.2.6.6 Business Strategy
    • 1.2.6.7 Recent Developments
    • 1.2.6.8 Management Change
    • 1.2.6.9 S.W.O.T Analysis
  • 1.2.7 Ypsomed (Switzerland)
    • 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.7.2 Business Overview
    • 1.2.7.3 Financials (Subject to data availability)
    • 1.2.7.4 R&D Investment (Subject to data availability)
    • 1.2.7.5 Product Types Specification
    • 1.2.7.6 Business Strategy
    • 1.2.7.7 Recent Developments
    • 1.2.7.8 Management Change
    • 1.2.7.9 S.W.O.T Analysis
  • 1.2.8 Animas (U.S.)
    • 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.8.2 Business Overview
    • 1.2.8.3 Financials (Subject to data availability)
    • 1.2.8.4 R&D Investment (Subject to data availability)
    • 1.2.8.5 Product Types Specification
    • 1.2.8.6 Business Strategy
    • 1.2.8.7 Recent Developments
    • 1.2.8.8 Management Change
    • 1.2.8.9 S.W.O.T Analysis
  • 1.2.9 Insulet (U.S.)
    • 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.9.2 Business Overview
    • 1.2.9.3 Financials (Subject to data availability)
    • 1.2.9.4 R&D Investment (Subject to data availability)
    • 1.2.9.5 Product Types Specification
    • 1.2.9.6 Business Strategy
    • 1.2.9.7 Recent Developments
    • 1.2.9.8 Management Change
    • 1.2.9.9 S.W.O.T Analysis
  • 1.2.10 Bayer (Germany)
    • 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.10.2 Business Overview
    • 1.2.10.3 Financials (Subject to data availability)
    • 1.2.10.4 R&D Investment (Subject to data availability)
    • 1.2.10.5 Product Types Specification
    • 1.2.10.6 Business Strategy
    • 1.2.10.7 Recent Developments
    • 1.2.10.8 Management Change
    • 1.2.10.9 S.W.O.T Analysis
  • 1.2.11 Nipro (Japan)
    • 1.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.11.2 Business Overview
    • 1.2.11.3 Financials (Subject to data availability)
    • 1.2.11.4 R&D Investment (Subject to data availability)
    • 1.2.11.5 Product Types Specification
    • 1.2.11.6 Business Strategy
    • 1.2.11.7 Recent Developments
    • 1.2.11.8 Management Change
    • 1.2.11.9 S.W.O.T Analysis
  • 1.2.12 Terumo (Japan)
    • 1.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.12.2 Business Overview
    • 1.2.12.3 Financials (Subject to data availability)
    • 1.2.12.4 R&D Investment (Subject to data availability)
    • 1.2.12.5 Product Types Specification
    • 1.2.12.6 Business Strategy
    • 1.2.12.7 Recent Developments
    • 1.2.12.8 Management Change
    • 1.2.12.9 S.W.O.T Analysis
  • 1.2.13 Arkray (Japan)
    • 1.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.13.2 Business Overview
    • 1.2.13.3 Financials (Subject to data availability)
    • 1.2.13.4 R&D Investment (Subject to data availability)
    • 1.2.13.5 Product Types Specification
    • 1.2.13.6 Business Strategy
    • 1.2.13.7 Recent Developments
    • 1.2.13.8 Management Change
    • 1.2.13.9 S.W.O.T Analysis
  • 1.2.14 Acon Laboratories (U.S.)
    • 1.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.14.2 Business Overview
    • 1.2.14.3 Financials (Subject to data availability)
    • 1.2.14.4 R&D Investment (Subject to data availability)
    • 1.2.14.5 Product Types Specification
    • 1.2.14.6 Business Strategy
    • 1.2.14.7 Recent Developments
    • 1.2.14.8 Management Change
    • 1.2.14.9 S.W.O.T Analysis
  • 1.2.15 Freestyle (U.S.)
    • 1.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.15.2 Business Overview
    • 1.2.15.3 Financials (Subject to data availability)
    • 1.2.15.4 R&D Investment (Subject to data availability)
    • 1.2.15.5 Product Types Specification
    • 1.2.15.6 Business Strategy
    • 1.2.15.7 Recent Developments
    • 1.2.15.8 Management Change
    • 1.2.15.9 S.W.O.T Analysis
  • 1.2.16 One Touch (U.S.)
    • 1.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.16.2 Business Overview
    • 1.2.16.3 Financials (Subject to data availability)
    • 1.2.16.4 R&D Investment (Subject to data availability)
    • 1.2.16.5 Product Types Specification
    • 1.2.16.6 Business Strategy
    • 1.2.16.7 Recent Developments
    • 1.2.16.8 Management Change
    • 1.2.16.9 S.W.O.T Analysis
  • 1.2.17 Accu-Chek (Germany)
    • 1.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.17.2 Business Overview
    • 1.2.17.3 Financials (Subject to data availability)
    • 1.2.17.4 R&D Investment (Subject to data availability)
    • 1.2.17.5 Product Types Specification
    • 1.2.17.6 Business Strategy
    • 1.2.17.7 Recent Developments
    • 1.2.17.8 Management Change
    • 1.2.17.9 S.W.O.T Analysis
  • 1.2.18 Dario (U.S.)
    • 1.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.18.2 Business Overview
    • 1.2.18.3 Financials (Subject to data availability)
    • 1.2.18.4 R&D Investment (Subject to data availability)
    • 1.2.18.5 Product Types Specification
    • 1.2.18.6 Business Strategy
    • 1.2.18.7 Recent Developments
    • 1.2.18.8 Management Change
    • 1.2.18.9 S.W.O.T Analysis
  • 1.2.19 iHealth (China)
    • 1.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.19.2 Business Overview
    • 1.2.19.3 Financials (Subject to data availability)
    • 1.2.19.4 R&D Investment (Subject to data availability)
    • 1.2.19.5 Product Types Specification
    • 1.2.19.6 Business Strategy
    • 1.2.19.7 Recent Developments
    • 1.2.19.8 Management Change
    • 1.2.19.9 S.W.O.T Analysis
  • 1.2.20 FreeStyle Libre (UK)
    • 1.2.20.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
    • 1.2.20.2 Business Overview
    • 1.2.20.3 Financials (Subject to data availability)
    • 1.2.20.4 R&D Investment (Subject to data availability)
    • 1.2.20.5 Product Types Specification
    • 1.2.20.6 Business Strategy
    • 1.2.20.7 Recent Developments
    • 1.2.20.8 Management Change
    • 1.2.20.9 S.W.O.T Analysis

Chapter 2. Global Point of Care Glucose Testing Market Analysis

• 2.1 Global Point of Care Glucose Testing Market Analysis
• 2.2 Global Point of Care Glucose Testing Market Analysis by Region
• 2.3 Global Point of Care Glucose Testing Market Analysis by Product
• 2.4 Global Point of Care Glucose Testing Market Analysis by Type
• 2.5 Global Point of Care Glucose Testing Market Analysis by Application
• 2.6 Global Point of Care Glucose Testing Market Analysis by End User
• 2.7 Global Point of Care Glucose Testing Market Analysis by Conclusion
• 2.8 Global Point of Care Glucose Testing Market Analysis by Key Players

Chapter 3. North America Point of Care Glucose Testing Market Analysis

• 3.1 North America Point of Care Glucose Testing Market Analysis
• 3.2 North America Point of Care Glucose Testing Market Analysis by Country
• 3.3 North America Point of Care Glucose Testing Market Analysis by Product
• 3.4 North America Point of Care Glucose Testing Market Analysis by Type
• 3.5 North America Point of Care Glucose Testing Market Analysis by Application
• 3.6 North America Point of Care Glucose Testing Market Analysis by End User
• 3.7 North America Point of Care Glucose Testing Market Analysis by Conclusion
• 3.8 North America Point of Care Glucose Testing Market Analysis by Key Players

Chapter 4. Europe Point of Care Glucose Testing Market Analysis

• 4.1 Europe Point of Care Glucose Testing Market Analysis
• 4.2 Europe Point of Care Glucose Testing Market Analysis by Country
• 4.3 Europe Point of Care Glucose Testing Market Analysis by Product
• 4.4 Europe Point of Care Glucose Testing Market Analysis by Type
• 4.5 Europe Point of Care Glucose Testing Market Analysis by Application
• 4.6 Europe Point of Care Glucose Testing Market Analysis by End User
• 4.7 Europe Point of Care Glucose Testing Market Analysis by Conclusion
• 4.8 Europe Point of Care Glucose Testing Market Analysis by Key Players

Chapter 5. Asia Pacific Point of Care Glucose Testing Market Analysis

• 5.1 Asia Pacific Point of Care Glucose Testing Market Analysis
• 5.2 Asia Pacific Point of Care Glucose Testing Market Analysis by Country
• 5.3 Asia Pacific Point of Care Glucose Testing Market Analysis by Product
• 5.4 Asia Pacific Point of Care Glucose Testing Market Analysis by Type
• 5.5 Asia Pacific Point of Care Glucose Testing Market Analysis by Application
• 5.6 Asia Pacific Point of Care Glucose Testing Market Analysis by End User
• 5.7 Asia Pacific Point of Care Glucose Testing Market Analysis by Conclusion
• 5.8 Asia Pacific Point of Care Glucose Testing Market Analysis by Key Players

Chapter 6. South America Point of Care Glucose Testing Market Analysis

• 6.1 South America Point of Care Glucose Testing Market Analysis
• 6.2 South America Point of Care Glucose Testing Market Analysis by Country
• 6.3 South America Point of Care Glucose Testing Market Analysis by Product
• 6.4 South America Point of Care Glucose Testing Market Analysis by Type
• 6.5 South America Point of Care Glucose Testing Market Analysis by Application
• 6.6 South America Point of Care Glucose Testing Market Analysis by End User
• 6.7 South America Point of Care Glucose Testing Market Analysis by Conclusion
• 6.8 South America Point of Care Glucose Testing Market Analysis by Key Players

Chapter 7. Middle East Point of Care Glucose Testing Market Analysis

• 7.1 Middle East Point of Care Glucose Testing Market Analysis
• 7.2 Middle East Point of Care Glucose Testing Market Analysis by Country
• 7.3 Middle East Point of Care Glucose Testing Market Analysis by Product
• 7.4 Middle East Point of Care Glucose Testing Market Analysis by Type
• 7.5 Middle East Point of Care Glucose Testing Market Analysis by Application
• 7.6 Middle East Point of Care Glucose Testing Market Analysis by End User
• 7.7 Middle East Point of Care Glucose Testing Market Analysis by Conclusion
• 7.8 Middle East Point of Care Glucose Testing Market Analysis by Key Players

Chapter 8. Africa Point of Care Glucose Testing Market Analysis

• 8.1 Africa Point of Care Glucose Testing Market Analysis
• 8.2 Africa Point of Care Glucose Testing Market Analysis by Country
• 8.3 Africa Point of Care Glucose Testing Market Analysis by Product
• 8.4 Africa Point of Care Glucose Testing Market Analysis by Type
• 8.5 Africa Point of Care Glucose Testing Market Analysis by Application
• 8.6 Africa Point of Care Glucose Testing Market Analysis by End User
• 8.7 Africa Point of Care Glucose Testing Market Analysis by Conclusion
• 8.8 Africa Point of Care Glucose Testing Market Analysis by Key Players

Chapter 9. Product Analysis

• 9.1 Accu Check Aviva Meter
  • 9.1.1 Global Accu Check Aviva Meter Market
  • 9.1.2 Global Accu Check Aviva Meter Market by Region
• 9.2 Onetouch Verio Flex
  • 9.2.1 Global Onetouch Verio Flex Market
  • 9.2.2 Global Onetouch Verio Flex Market by Region
• 9.3 i-STAT
  • 9.3.1 Global i-STAT Market
  • 9.3.2 Global i-STAT Market by Region
• 9.4 Bayer CONTOUR Blood Glucose Monitoring System
  • 9.4.1 Global Bayer CONTOUR Blood Glucose Monitoring System Market
  • 9.4.2 Global Bayer CONTOUR Blood Glucose Monitoring System Market by Region
• 9.5 Freestyle Lite
  • 9.5.1 Global Freestyle Lite Market
  • 9.5.2 Global Freestyle Lite Market by Region
• 9.6 True Metrix
  • 9.6.1 Global True Metrix Market
  • 9.6.2 Global True Metrix Market by Region
• 9.7 Accu-Chek Inform II
  • 9.7.1 Global Accu-Chek Inform II Market
  • 9.7.2 Global Accu-Chek Inform II Market by Region
• 9.8 StatStrip
  • 9.8.1 Global StatStrip Market
  • 9.8.2 Global StatStrip Market by Region
• 9.9 Others
  • 9.9.1 Global Others Market
  • 9.9.2 Global Others Market by Region

Chapter 10. Type Analysis

• 10.1 Strips
  • 10.1.1 Global Strips Market
  • 10.1.2 Global Strips Market by Region
• 10.2 Lancets and Lancing Devices
  • 10.2.1 Global Lancets and Lancing Devices Market
  • 10.2.2 Global Lancets and Lancing Devices Market by Region
• 10.3 Meters
  • 10.3.1 Global Meters Market
  • 10.3.2 Global Meters Market by Region

Chapter 11. Application Analysis

• 11.1 Type-1 Diabetes
  • 11.1.1 Global Type-1 Diabetes Market
  • 11.1.2 Global Type-1 Diabetes Market by Region
• 11.2 Type-2 Diabetes
  • 11.2.1 Global Type-2 Diabetes Market
  • 11.2.2 Global Type-2 Diabetes Market by Region

Chapter 12. End User Analysis

• 12.1 Hospitals and Clinics
  • 12.1.1 Global Hospitals and Clinics Market
  • 12.1.2 Global Hospitals and Clinics Market by Region
• 12.2 Home Care Settings
  • 12.2.1 Global Home Care Settings Market
  • 12.2.2 Global Home Care Settings Market by Region
• 12.3 Others
  • 12.3.1 Global Others Market
  • 12.3.2 Global Others Market by Region

Chapter 13. Conclusion Analysis

Chapter 14. Qualitative Analysis (Subject to Data Availability)

• 14.1 Market Drivers
• 14.2 Market Restraints
• 14.3 Market Trends
• 14.4 Market Opportunity
• 14.5 Technological Road Map (Subject to Data Availability)
• 14.6 Product Life Cycle (Subject to Data Availability)
• 14.7 Customer and Buyer Behavior Analysis
  • 14.7.1 Digital Engagement, Customer Experience & Relationship Analysis
  • 14.7.2 Customer Buying Behavior & Purchase Decision Analysis
  • 14.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
  • 14.7.4 Pricing, Affordability & Value Perception Analysis
  • 14.7.5 Customer Segmentation & Demand Pattern Analysis
• 14.8 PESTEL Analysis
  • 14.8.1 Political Factors
  • 14.8.2 Economic Factors
  • 14.8.3 Social Factors
  • 14.8.4 Technological Factors
  • 14.8.5 Legal Factors
  • 14.8.6 Environmental Factors
• 14.9 Industrial Chain Analysis (Subject to Data Availability)
  • 14.9.1 Industry Chain Analysis
  • 14.9.2 Manufacturing Cost Analysis
  • 14.9.3 Supply Side Analysis
    • 14.9.3.1 Raw Material Analysis
    • 14.9.3.2 Raw Material Procurement Analysis
    • 14.9.3.3 Raw Material Price Trend Analysis
• 14.10 Porter’s Five Forces Analysis
  • 14.10.1 Bargaining Power of Suppliers
  • 14.10.2 Bargaining Power of Buyers
  • 14.10.3 Threat of New Entrants
  • 14.10.4 Threat of Substitutes
  • 14.10.5 Degree of Competition
• 14.11 Patent Analysis (Subject to Data Availability)
• 14.12 ESG Analysis
• 14.13 Geopolitical Outlook
  • 14.13.1 Global Power Realignment & Strategic Alliances
  • 14.13.2 Geopolitical Risk Landscape & Conflict Hotspots
  • 14.13.3 International Trade Relations & Market Access Environment
  • 14.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
  • 14.13.5 Supply Chain Resilience, Localization & Resource Nationalism
  • 14.13.6 Technology Sovereignty & Digital Geopolitics
  • 14.13.7 Strategic Implications for Investment, Growth & Market Entry
• 14.14 AI & Market Transformation
  • 14.14.1 Competitive Landscape Disruption & Strategic Shifts
  • 14.14.2 AI-Driven Transformation of Industry Value Chain
  • 14.14.3 Evolution of Business Models & Revenue Streams
  • 14.14.4 AI-Driven Product, Service & Innovation Transformation
  • 14.14.5 Customer Behavior, AI Adoption & Future Market Evolution

Chapter 15. TOP 10 Country Analysis

• 15.1 Country 1
• 15.2 Country 2
• 15.3 Country 3
• 15.4 Country 4
• 15.5 Country 5
• 15.6 Country 6
• 15.7 Country 7
• 15.8 Country 8
• 15.9 Country 9
• 15.10 Country 10

Chapter 16. Research Findings

• 16.1 Key Takeaways
• 16.2 Analyst Point of View
• 16.3 Assumptions and Acronyms

Chapter 17. Research Methodology and Sources

• 17.1 Primary Data Collection
  • 17.1.1 Steps for Primary Data Collection
    • 17.1.1.1 Identification of KOL
  • 17.1.2 Backward Integration
  • 17.1.3 Forward Integration
  • 17.1.4 How Primary Research Help Us
  • 17.1.5 Modes of Primary Research
• 17.2 Secondary Research
  • 17.2.1 How Secondary Research Help Us
  • 17.2.2 Sources of Secondary Research
• 17.3 Data Validation
  • 17.3.1 Data Triangulation
• 17.4 Data Representation